Eaton Vance Worldwide Health Sciences does not have any notable advantages over its rivals, and the strategy retains its Average People and Process ratings.
Eaton Vance Worldwide Health Sciences Fund Class A ETHSX
- NAV / 1-Day Return $13.65 / +2.48 %
- Fund Size $779.0M
- Adjusted Expense Ratio 1.180%
- Net Expense Ratio 1.170%
- Fee Level: Distribution Below Average
- Share Class Type Front Load
- Morningstar Category Health
- Equity Style Box (Funds) Large Value
- Minimum Initial Investment $1,000
- Investment Status Open
- TTM Yield 0.51%
- Turnover Ratio 30%
Morningstar’s Analysis ETHSX
Will ETHSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 58.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 11.99 | 96M | Healthcare |
Johnson & Johnson | 7.17 | 58M | Healthcare |
AbbVie Inc | 7.17 | 58M | Healthcare |
Merck & Co Inc | 5.96 | 48M | Healthcare |
Roche Holding AG | 5.32 | 43M | — |
UnitedHealth Group Inc | 5.30 | 43M | Healthcare |
AstraZeneca PLC | 4.29 | 34M | Healthcare |
Bristol-Myers Squibb Co | 4.27 | 34M | Healthcare |
Vertex Pharmaceuticals Inc | 3.84 | 31M | Healthcare |
Abbott Laboratories | 3.30 | 27M | Healthcare |
United States